International Biotechnology Trust (CHIX:IBTL) ROE % Adjusted to Book Value : 16.48% (As of Aug. 2024)

View and export this data going back to 2015. Start your Free Trial

What is International Biotechnology Trust ROE % Adjusted to Book Value?

International Biotechnology Trust's ROE % for the quarter that ended in Aug. 2024 was 14.83%. International Biotechnology Trust's PB Ratio for the quarter that ended in Aug. 2024 was 0.90. International Biotechnology Trust's ROE % Adjusted to Book Value for the quarter that ended in Aug. 2024 was 16.48%.

International Biotechnology Trust ROE % Adjusted to Book Value Historical Data

The historical data trend for International Biotechnology Trust's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

International Biotechnology Trust ROE % Adjusted to Book Value Chart

International Biotechnology Trust Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

20.41

9.87

-7.53

2.63

15.63

International Biotechnology Trust Quarterly Data
	Feb15	Aug15	Feb16	Aug16	Feb17	Aug17	Feb18	Aug18	Feb19	Aug19	Feb20	Aug20	Feb21	Aug21	Feb22	Aug22	Feb23	Aug23	Feb24	Aug24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															38.69	24.87	-15.43	44.25	16.48

Competitive Comparison of International Biotechnology Trust's ROE % Adjusted to Book Value

For the Biotechnology subindustry, International Biotechnology Trust's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

International Biotechnology Trust's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, International Biotechnology Trust's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where International Biotechnology Trust's ROE % Adjusted to Book Value falls into.

International Biotechnology Trust ROE % Adjusted to Book Value Calculation

International Biotechnology Trust's ROE % Adjusted to Book Value for the fiscal year that ended in Aug. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	14.07%	/	0.90
	=	15.63%

International Biotechnology Trust's ROE % Adjusted to Book Value for the quarter that ended in Aug. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	14.83%	/	0.90
	=	16.48%

International Biotechnology Trust ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of International Biotechnology Trust's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

International Biotechnology Trust Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » International Biotechnology Trust PLC (CHIX:IBTl) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

IBT:UK

Address

65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ

Website

https://www.ibtplc.com

International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments ,and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.